HIV Drugs Market Size, Share, Growth, Leading Companies, Global Industry Analysis and Forecast to 2027
IMARC Group, a leading market research company, has recently releases report titled “HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, The study provides a detailed analysis of the industry, including the global HIV drugs market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the HIV drug market?
|Market Size in 2021||US$ 29.2 Billion|
|Market Forecast in 2027||US$ 38.9 Billion|
|Growth rate (2022 to 2027)||CAGR of 3.7%|
|Base Year of the Analysis||2022|
What is HIV Drug?
HIV or human immunodeficiency virus is a type of virus that attacks the immune system of the body. It can turn into a more serious and life-threatening diseases, acquired immunodeficiency syndrome (AIDS), if not treated timely. Such a virus is spread by contact with certain bodily fluids of a person with HIV, most commonly during unprotected sexual contact or through sharing the same syringe. HIV is treated with antiretroviral medicines that work by stopping the virus from replicating in the body, which allows the immune system to fix itself and prevent further damage.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/hiv-drug-market/requestsample
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
What are the growth prospects and trends in the HIV drugs industry?
The increasing prevalence of HIV represents one of the key factors driving the market growth. Moreover, the rising awareness about HIV infection among people is facilitating the demand for HIV drugs. Apart from this, the significant expansion in the healthcare industry, along with the rising patient population and the continual launch of novel drugs are expected to fuel the growth of the market. The increasing number of awareness programs organized by both the government and non-government organizations (NGOs) is acting another major growth-inducing factor. Other factors, such as the rising demand for antiretroviral therapies (ARTs), along with the presence of several multinational pharmaceutical companies and generic drug manufacturers, are creating a positive outlook for the market further across the globe.
Competitive Landscape With Key Players:
The competitive landscape of the HIV drugs market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Boehringer Ingelheim International GmbH,
- Merck & Co., Inc.,
- ViiV Healthcare,
- AbbVie, F. Hoffmann-La Roche Ltd.,
- Teva Pharmaceutical Industries Ltd.,
- Bristol-Myers Squibb Gilead Sciences, Inc.,
- Johnson & Johnson,
- Cipla Limited,
- Daiichi Sankyo,
- Hetero Drugs,
Key Market Segmentation:
The report has segmented the global HIV drugs market on the basis of breakup by drug class, distribution channel and region.
Breakup by Drug Class:
- Nucleoside Reverse Transcriptase Inhibitors
- Multi-Class Combination Products
- Protease Inhibitors
- HIV Integrase Strand Transfer Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Entry Inhibitors — CCR5 Co-Receptor Antagonist
- Fusion Inhibitors and Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/hiv-drug-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Follow us on Twitter: @imarcglobal